Asset Managers Explain Why Investors Should Not Panic About IL&FS’ Debt Woes
Investors shouldn't panic because of Infrastructure Leasing & Financial Services Ltd.'s debt defaults, according to at least two asset managers.
“It doesn't look like it will evolve into something larger because the regulators are taking action and the mutual fund industry is well-equipped to deal with this,” Mahendra Kumar Jajoo, head of fixed income investments at Mirae Asset Global Investments, said in an interview with BloombergQuint.
Lakshmi Iyer, chief investment officer of fixed income at Kotak Asset Management Company, said IL&FS is an evolving situation and it's in the interest of the industry not to panic. It's important for investors to stay the course, she said, adding that the situation is nowhere close to the 2008 crisis and much of it can be reversed in an orderly manner.
India's benchmark indices fell more than 3 percent intraday on Friday, swinging the most in four years, on liquidity concerns over non-bank lenders, especially housing finance companies. Shares of Dewan Housing Finance Company Ltd. had plunged as much as 60 percent after reports that DSP Mutual Fund sold its bonds at a higher yield.
Banking and financial market regulators, along with the country's largest bank, on Sunday reassured nervous credit markets, saying that they stand ready to step in to ensure smooth functioning of the financial markets. The Reserve Bank of India will also meet shareholders of IL&FS on Sept. 28 to discuss a capital-infusion plan.
Mutual funds that invested in IL&FS have already marked down NAVs based on their exposure. Yet, mutual fund investors need to worry, according to Jajoo. “Most of the exposure of mutual funds is to very good companies.”
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.